Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ANIK holding history

Anika Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ANIK overviewAll 13F holders of ANIKFull Q2 2026 holdings

Shares (Q2 2026)
245,066
Value
$3.59M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ANIK by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026245,066$3.59M<0.1%+15,270+6.6%AddedHolders
Q1 2026229,796$3.33M<0.1%−68,183−22.9%ReducedHolders
Q4 2025297,979$2.86M<0.1%+122,664+70.0%AddedHolders
Q3 2025175,315$1.65M<0.1%+51,236+41.3%AddedHolders
Q2 2025124,079$1.31M<0.1%−43,681−26.0%ReducedHolders
Q1 2025167,760$2.52M<0.1%+13,996+9.1%AddedHolders
Q4 2024153,764$2.53M<0.1%−297−0.2%ReducedHolders
Q3 2024154,061$3.81M<0.1%+1,138+0.7%AddedHolders
Q2 2024152,923$3.87M<0.1%−566−0.4%ReducedHolders
Q1 2024153,489$3.90M<0.1%−15,755−9.3%ReducedHolders
Q4 2023169,244$3.84M<0.1%−22,821−11.9%ReducedHolders
Q3 2023192,065$3.58M<0.1%+48,388+33.7%AddedHolders
Q2 2023143,677$3.73M<0.1%+5,410+3.9%AddedHolders
Q1 2023138,267$3.97M<0.1%−7,359−5.1%ReducedHolders
Q4 2022145,626$4.31M<0.1%−6,402−4.2%ReducedHolders
Q3 2022152,028$3.62M<0.1%−40,732−21.1%ReducedHolders
Q2 2022192,760$4.30M<0.1%+22,371+13.1%AddedHolders
Q1 2022170,389$4.28M<0.1%+8,714+5.4%AddedHolders
Q4 2021161,675$5.79M<0.1%−16,207−9.1%ReducedHolders
Q3 2021177,882$7.57M<0.1%−14,934−7.7%ReducedHolders
Q2 2021192,816$8.35M<0.1%+443+0.2%AddedHolders
Q1 2021192,373$7.85M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.